That's a good point and here is the reason why. I have been following this ever since the CEO who bought out Daraprim jacked the price up. Long story short, the pill was $13 and a young greedy CEO jacked it up to $750 a pill. Problem is it takes 100-1000 pills in order to be fully cured. So with the new increase people are being turned down for treatment from their insurance companies and are unable to get the medicine. The Daraprim CEO had at one point said if insurance turned anyone down they could have the drug for free...but never held his word. So now IMMY is looking to help people who can't afford the treatment. So instead of paying $75,000-$750,000 dollars people will at most have to pay $1,000 for treatment. Could they jack it up, sure... but I think the idea is to help people get treated. Sure it would mean 500 times the rev for shareholders if they went to $5 and they may do it in the future. For now, I am just happy to see a non-greedy company trying to help people without taking their life savings. As an investor, I get your point...as an American/vet/human/person/etc... It is nice to finally see people taking care of people.